12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/21/25 17:10
2/19/25
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS-194.410-4-2220D
2/21/25 17:09
2/19/25
LXEOHealthBioPrdBiological Products, (No DiagSee Tai SandiNYOChief DeS-74.410-1-354D
2/21/25 17:09
2/19/25
LXEOHealthBioPrdBiological Products, (No DiagAdler EricNYOChief MeS-104.410-2-368D
2/21/25 17:08
2/19/25
LXEOHealthBioPrdBiological Products, (No DiagRobertson JennyNYOGCS-94.410-2-458D
12/12/24 17:00
12/10/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-208.200-3-2121D
11/13/24 17:33
11/11/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-207.820-3-2121D
10/15/24 13:45
10/10/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-408.100-5-4121D
9/11/24 17:17
9/10/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-5310.650-5-4121D
8/13/24 18:34
8/12/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-5811.530-5-4121D
7/12/24 16:55
7/10/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.dm-92316.790-55-31121D
6/12/24 17:00
6/10/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-8817.650-5-3171D
5/14/24 16:04
5/13/24
LXEOHealthBioPrdBiological Products, (No DiagTownsend Richard NolanNYDOCEOS.d-6613.220-5-3171D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact